MAPT and Alzheimer disease: Furthermore, a patient with an intermediate bisecting GlcNAc‐to‐tau ratio in CSF was found to have an elevated risk of AD, with a hazard ratio of 2.06 and a 95% confidence interval (CI) of 1.18‐3.6.134, 135